Fountain Valley, CA1 Active Studies

Ulcerative Colitis Clinical Trials in Fountain Valley, CA

Find 1 actively recruiting ulcerative colitis clinical trials in Fountain Valley, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
75
Enrolling

Recruiting Ulcerative Colitis Studies in Fountain Valley

About Ulcerative Colitis Clinical Trials in Fountain Valley

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 1 ulcerative colitis clinical trials recruiting participants in Fountain Valley, CA. These studies are seeking a combined 75 participants. Research is being sponsored by University of California, Los Angeles. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Fountain Valley — FAQ

Are there ulcerative colitis clinical trials in Fountain Valley?

Yes, there are 1 ulcerative colitis clinical trials currently recruiting in Fountain Valley, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fountain Valley?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fountain Valley research site will contact you about next steps.

Are clinical trials in Fountain Valley free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fountain Valley studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 1 active trials in Fountain Valley are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated July 17, 2026 from ClinicalTrials.gov